122 related articles for article (PubMed ID: 3987208)
41. Short-term effects of cigarette smoking on bronchial clearance in humans.
Arch Environ Health; 1975 Jul; 30(7):361-7. PubMed ID: 1147701
[TBL] [Abstract][Full Text] [Related]
42. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus.
Hyo N; Takano H; Hyo Y
Rhinology; 1989 Mar; 27(1):17-26. PubMed ID: 2740721
[TBL] [Abstract][Full Text] [Related]
43. Tracheobronchial deposition and clearance in small airways in asthmatic subjects.
Svartengren K; Philipson K; Svartengren M; Anderson M; Camner P
Eur Respir J; 1996 Jun; 9(6):1123-9. PubMed ID: 8804926
[TBL] [Abstract][Full Text] [Related]
44. The effect of exercise on the deposition of an inhaled aerosol.
Morgan WK; Ahmad D; Chamberlain MJ; Clague HW; Pearson MG; Vinitski S
Respir Physiol; 1984 Jun; 56(3):327-38. PubMed ID: 6473946
[TBL] [Abstract][Full Text] [Related]
45. Aerosol transport in the human lung from analysis of single breaths.
Taulbee DB; Yu CP; Heyder J
J Appl Physiol Respir Environ Exerc Physiol; 1978 May; 44(5):803-12. PubMed ID: 649480
[TBL] [Abstract][Full Text] [Related]
46. The fractional deposition of inhaled 2 and 5 mum particles in the alveolar and tracheobronchial regions of the healthy human lung.
Pavia D; Thomson ML
Ann Occup Hyg; 1976 Nov; 19(2):109-14. PubMed ID: 1008402
[No Abstract] [Full Text] [Related]
47. Lung clearance of inhaled 99Tcm-erythromycin lactobionate in non-smokers and smokers.
Durak H; Sayit E; Aktoğu S; Değirmenci B; Yürekli Y; Ertay T; Güven H
Nucl Med Commun; 1996 Oct; 17(10):895-901. PubMed ID: 8951912
[TBL] [Abstract][Full Text] [Related]
48. Deposition of inhaled particles in the mouth and throat of asthmatic subjects.
Svartengren K; Lindestad PA; Svartengren M; Bylin G; Philipson K; Camner P
Eur Respir J; 1994 Aug; 7(8):1467-73. PubMed ID: 7957832
[TBL] [Abstract][Full Text] [Related]
49. Regional deposition in human lung of 2.5 microM particles.
Svartengren M; Linnman L; Philipson K; Camner P
Exp Lung Res; 1987; 12(4):265-79. PubMed ID: 3582281
[TBL] [Abstract][Full Text] [Related]
50. Effects of inhaled iron oxide particles on alveolar epithelial permeability in normal subjects.
Lay JC; Zeman KL; Ghio AJ; Bennett WD
Inhal Toxicol; 2001 Dec; 13(12):1065-78. PubMed ID: 11696874
[TBL] [Abstract][Full Text] [Related]
51. Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans.
Chan TL; Lippmann M
Am Ind Hyg Assoc J; 1980 Jun; 41(6):399-409. PubMed ID: 7395753
[TBL] [Abstract][Full Text] [Related]
52. Characterization of exhaled particles from the human lungs in airway obstruction.
Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
[TBL] [Abstract][Full Text] [Related]
53. Alveolar deposition of inhaled particles in humans.
Heyder J
Am Ind Hyg Assoc J; 1982 Nov; 43(11):864-6. PubMed ID: 7168445
[TBL] [Abstract][Full Text] [Related]
54. Flow and particle dispersion in a pulmonary alveolus--part I: velocity measurements and convective particle transport.
Chhabra S; Prasad AK
J Biomech Eng; 2010 May; 132(5):051009. PubMed ID: 20459210
[TBL] [Abstract][Full Text] [Related]
55. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women.
Jaques PA; Kim CS
Inhal Toxicol; 2000 Aug; 12(8):715-31. PubMed ID: 10880153
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary deposition of inhaled particles with diameters in the range 2.5 to 7.5 micron.
Foord N; Black A; Walsh M
Inhaled Part; 1975 Sep; 4 Pt 1():137-49. PubMed ID: 1236153
[TBL] [Abstract][Full Text] [Related]
57. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease.
Anderson PJ; Wilson JD; Hiller FC
Chest; 1990 May; 97(5):1115-20. PubMed ID: 2331906
[TBL] [Abstract][Full Text] [Related]
58. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
59. Determining deposition sites of inhaled lung particles and their effect on clearance.
Langenback EG; Bergofsky EH; Halpern JG; Foster WM
J Appl Physiol (1985); 1990 Apr; 68(4):1427-34. PubMed ID: 2347784
[TBL] [Abstract][Full Text] [Related]
60. Intratracheal instillation versus intratracheal-inhalation of tracer particles for measuring lung clearance function.
Oberdörster G; Cox C; Gelein R
Exp Lung Res; 1997; 23(1):17-34. PubMed ID: 9028797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
